|12:50 PM||Guided vs. Potent P2Y12 Inhibitor Therapy: Updated Evidence
Lecturer: Dominick J. Angiolillo
|1:02 PM||Tools for Guided Antithrombotic Strategies: Genotyping, Platelet Function, and Others
Lecturer: Tullio Palmerini
|1:14 PM||Optimal Antithrombotic Therapy After PCI in Asia (Japan): Why We Are Going Our Own Way?
Lecturer: Takeshi Kimura
|1:26 PM||Interactive Discussion With Audience Q&A|
|1:38 PM||DAPT Study vs. Contemporary Trials: How Can We Reduce the Knowledge Gap?
Lecturer: Robert W. Yeh
|1:50 PM||DAPT Duration and NOAC Selection in the Afib-PCI Patient
Lecturer: Renato D. Lopes
|2:02 PM||Long-Term Antithrombotic Strategy in PCI and AF Patients: Insights From the AFIRE Trial
Lecturer: Satoshi Yasuda
|2:14 PM||Interactive Discussion With Audience Q&A|